Moreover, IL-21 blockade and ablation of IL-21 signaling in lupus-prone mice ameliorate disease symptoms by reducing total B cells, plasmablasts and autoantibody titers34,43,44. This evidence concerns the gene IL21 and systemic lupus erythematosus.